Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Streetwise Reports (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Gold Miner Boosts Reserves by 86% Year Over Year

% of readers think this story is Fact. Add your two cents.


Source: Streetwise Reports   02/15/2018

BMO Capital Markets analyst Andrew Kaip shared the highlights of this company’s recently reported mineral reserves.

In a Feb. 12, 2018, research note titled “2017: A Year of Reserve Growth,” Andrew Kaip, an analyst with BMO Capital Markets, reported that Canada-based IAMGOLD Corp. (IMG:TSX; IAG:NYSE) released a reserves update. The mining company’s new numbers reflect an 86% year-over-year increase to 14.5 million ounces (14.5 Moz) of gold from 7.8 Moz of gold, assuming a price for the metal of $1,200 an ounce. The total encompasses an additional 3.8 Moz at Cote, 1.5 Moz at Rosebel and 1.4 Moz at Boto.

Measured and Indicated resources grew 6% to 24.7 Moz gold. Inferred resources expanded 44% to 8.8 Moz gold.

As for reserve grades, they generally were up at Sadiola but “down marginally” at Rosebel and Essakane,” Kaip indicated. At Westwood specifically, reserve grade dropped 13% to 7.7 grams per ton gold, which is “more realistic given mine grades continue to be below reserve grade.”

The analyst also noted the results of the recent prefeasibility study done on the Boto project. It shows an after-tax internal rate of return of 13.3% and a net present value 6% of $104 million ($104M). Based on a 1.4 Moz reserve, production is an estimated 100,000 ounces of gold per annum for 13.5 years. Capital costs are an estimated $249M. All-in-sustaining costs are expected to be $829 per ounce for the life of mine. Kaip added that these numbers “have yet to meet IAMGOLD’s investment threshold.”

To bolster project economics, the company is pursuing a feasibility study for Boto that will consider a 25% throughput increase.

BMO Capital has an Outperform rating and a $7 per share price target on IAMGOLD, whose stock is currently trading at around $6.02 per share.

Want to read more Gold Report articles like this? Sign up for our free e-newsletter, and you’ll learn when new articles have been published. To see a list of recent articles and interviews with industry analysts and commentators, visit our Streetwise Interviews page.

Disclosure:
1) Doresa Banning compiled this article for Streetwise Reports LLC and provides services to Streetwise Reports as an independent contractor. She or members of her household own securities of the following companies mentioned in the article: None. She or members of her household are paid by the following companies mentioned in this article: None.
2) The following companies mentioned in this article are billboard sponsors of Streetwise Reports: None. Streetwise Reports does not accept stock in exchange for its services. Click here for important disclosures about sponsor fees.
3) Comments and opinions expressed are those of the specific experts and not of Streetwise Reports or its officers. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.
4) The article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports’ terms of use and full legal disclaimer. This article is not a solicitation for investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.
5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the interview or the decision to write an article, until one week after the publication of the interview or article.

Disclosures from BMO Capital Markets, IAMGOLD, Feb. 12, 2018

Analyst’s Certification: I, Andrew Kaip, hereby certify that the views expressed in this report accurately reflect my personal views about the subject securities or issuers. I also certify that no part of my compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views expressed in this report.

Analysts who prepared this report are compensated based upon (among other factors) the overall profitability of BMO Capital Markets and their affiliates, which includes the overall profitability of investment banking services. Compensation for research is based on effectiveness in generating new ideas and in communication of ideas to clients, performance of recommendations, accuracy of earnings estimates, and service to clients.

Analysts employed by BMO Nesbitt Burns Inc. and/or BMO Capital Markets Limited are not registered as research analysts with FINRA. These analysts may not be associated persons of BMO Capital Markets Corp. and therefore may not be subject to the FINRA Rule 2241 restrictions on communications with a subject company, public appearances and trading securities held by a research analyst account.

Company Specific Disclosures

Disclosure 8A: BMO Capital Markets or an affiliate has a financial interest in 1% or more of any class of the equity securities of IAMGOLD.

Disclosure 8C: BMO Capital Markets or an affiliate has a financial interest in 0.5% or more in the issued share capital of IAMGOLD.

Disclosure 9: BMO Capital Markets makes a market in IAMGOLD.

Disclosure 16: A BMO Nesbitt Burns Inc. research analyst has extensively viewed the material operations of IAMGOLD.

Disclosure 17: IAMGOLD has paid or reimbursed some or all of the BMO Nesbitt Burns Inc. analysts travel expenses.

( Companies Mentioned: IMG:TSX; IAG:NYSE, )


Source: https://www.streetwisereports.com/article/2018/02/15/gold-miner-boosts-reserves-by-86-year-over-year.html


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Lion’s Mane Mushroom

Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, But it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes:

Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity.

Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins.

Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system.

Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome.

Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function.

Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules. Today Be 100% Satisfied Or Receive A Full Money Back Guarantee Order Yours Today By Following This Link.

Report abuse

    Comments

    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    MOST RECENT
    Load more ...

    SignUp

    Login

    Newsletter

    Email this story
    Email this story

    If you really want to ban this commenter, please write down the reason:

    If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.